16: A phase 3 randomized, double-blind, placebo-controlled study to confirm the efficacy and safety of a single, oral dose of SYM-1219, a granule formulation containing 2 grams of secnidazole, for the treatment of bacterial vaginosis

May 2, 2017 by in GYNECOLOGY Comments Off on 16: A phase 3 randomized, double-blind, placebo-controlled study to confirm the efficacy and safety of a single, oral dose of SYM-1219, a granule formulation containing 2 grams of secnidazole, for the treatment of bacterial vaginosis

Objectives SYM-1219, a granule formulation of secnidazole, is being developed as a single oral dose therapy for bacterial vaginosis (BV). A previous study of SYM-1219 for the treatment of BV…

read more

15: To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

May 2, 2017 by in GYNECOLOGY Comments Off on 15: To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC)

Objectives To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC). Methods…

read more

12: Modifiable risk factors for endomyometritis after cesarean section in the era of pre-operative antibiotic prophylaxis

May 2, 2017 by in GYNECOLOGY Comments Off on 12: Modifiable risk factors for endomyometritis after cesarean section in the era of pre-operative antibiotic prophylaxis

Objectives The objectives of this study were to identify the rate of postpartum endomyometritis (PPE) and determine modifiable risk factors for the development of PPE after cesarean delivery (CD) in…

read more

7: Relationships between host innate immune genetic variation, bacterial vaginosis, and bacterial colonization

May 2, 2017 by in GYNECOLOGY Comments Off on 7: Relationships between host innate immune genetic variation, bacterial vaginosis, and bacterial colonization

Objectives Our goals were to identify host innate immune genotypes associated with prevalent bacterial vaginosis (BV) and colonization with BV-associated bacteria (BVAB). Furthermore, we sought to characterize Lactobacillus colonization patterns…

read more
Get Clinical Tree app for offline access